Achromobacter xylosoxidans respiratory tract infections in cystic fibrosis patients

APMIS

Volumn 116, Issue 9, 2008, Pages 837-841

  Raso, Tiziana ^a   Bianco, Ornella ^b   Grosso, Bianca ^b   Zucca, Mario ^a   Savoia, Dianella ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b SAN LUIGI GONZAGA HOSPITAL   (Italy)

Author keywords

Achromobacter xylosoxidans; Antibiotic resistance; Cystic fibrosis; Genotype; Respiratory tract infections

Indexed keywords

AMIKACIN; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; PIPERACILLIN;

ACHROMOBACTER XYLOSOXIDANS; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; GENOTYPE; HUMAN; HUMAN TISSUE; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION;

ACHROMOBACTER DENITRIFICANS; ADULT; AGED; CYSTIC FIBROSIS; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; ITALY; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PREVALENCE; RESPIRATORY TRACT INFECTIONS; YOUNG ADULT;

EID: 57349152319     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2008.00995.x     Document Type: Article

References (22)

1. Saiman L, Siegel J. Infection control in cystic fibrosis. Clin Microbiol Rev 2004 17 : 57 71.
2. Steinkamp G, Wiedemann B, Rietschel E, Krahl A, Gielen J, Barmeier H, et al. Emerging bacteria study group. Prospective evaluation of emerging bacteria in cystic fibrosis. J Cyst Fibros 2005 4 : 41 8.
3. Lambiase A, Raia V, Del Pezzo M, Sepe A, Carnovale V, Rossano F. Microbiology of airway disease in a cohort of patients with Cystic Fibrosis. BMC Infect Dis 2006 6 : 4 11.
4. Davies JC, Rubin BK. Emerging and unusual gram-negative infections in cystic fibrosis. Semin Respir Crit Care Med 2007 28 : 312 21.
5. Tan K, Conway SP, Brownlee KG, Etherington C, Peckam DG. Alcaligenes infection in cystic fibrosis. Pediatr Pulmonol 2002 34 : 101 4.
6. De Baets F, Schelstraete P, Van Daele S, Haerynck F, Vaneechoutte M. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance. J Cyst Fibros 2007 6 : 75 8.
7. Saiman L, Macdonald N, Burns JL, Hoiby N, Speert DP, Weber D. Infection control in cystic fibrosis: pratical recommendation for the hospital, clinic, and social settings. Am J Infection Control 2000 5 : 381 5.
8. Dunne WM, Maisch S. Epidemiological investigation of infections due to Alcaligenes species in children and patients with cystic fibrosis: use of repetitive-element-sequence polymerase chain reaction. Clin Infect Dis 1995 20 : 836 41.
9. Vu-Thien H, Moissenet D, Valcin M, Dulot C, Tournier G, Garbarg-Chenon A. Molecular epidemiology of Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans in a cystic fibrosis center. Eur J Clin Microbiol Infect Dis 1996 15 : 876 9.
10. Krzewinski JW, Nguyen CD, Foster JM, Burns JL. Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis. J Clin Microbiol 2001 39 : 3597 602.
11. Moissenet D, Baculard A, Valcin M, Marchand V, Tournier G, Garbarg-Chenon A, et al. Colonization by Alcaligenes xylosoxidans in children with cystic fibrosis: a retrospective clinical study conducted by means of molecular epidemiological investigation. Clin Infect Dis 1997 24 : 274 5.
12. Peltroche-Llacsahuanga H, Haase G, Kentrup H. Persistent airway colonization with Alcaligenes xylosoxidans in two brothers with cystic fibrosis. Eur J Clin Microbiol Infect Dis 1998 17 : 132 4.
13. Rønne Hansen C, Pressler T, Hoiby N, Gormsen M. Chronic infection with Achromobacter xylosoxidans in cystic fibrosis patients; a retrospective case control study. J Cyst Fibros 2006 5 : 245 51.
14. Kanellopoulou M, Poumaras S, Iglezos H, Skarmoutsou N, Patafrangas E, Maniatis AN. Persistent colonization of nine cystic fibrosis patients with an Achromobacter (Alcaligenes) xylosoxidans clone. Eur J Clin Microbiol Infect Dis 2004 23 : 336 9.
15. Van daele S, Verhelst R, Claeys G, Verschraegen G, Franckx H, Van Simaey L, et al. Shared genotypes of Achromobacter xylosoxidans strains isolated from patients a cystic fibrosis rehabilitation center. J Clin Microbiol 2005 43 : 2998 3002.
16. Magni A, Giordano A, Mancini C, Pecoraro C, Varesi P, Quattrucci S, et al. Emerging cystic fibrosis pathogens: incidence and antimicrobial resistance. New Microbiologica 2007 30 : 59 62.
17. Allice T, Scutera S, Chirillo MG, Savoia D. Burkholderia respiratory tract infections in italian patients with cystic fibrosis: molecular characterization. J Infect 2006 53 : 159 65.
18. Cheron M, Abachin E, Guerot E, El-Bez M, Simonet M. Investigation of hospital-acquired infections due to Alcaligenes denitrificans subsp. xylosoxidans by DNA restriction fragment length polymorphism. J Clin Microbiol 1994 32 : 1023 6.
19. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995 33 : 2233 9.
20. Ferroni A, Sermet-Gaudelus I, Abachin E, Quesne G, Lenoir G, Berche P, et al. Use of 16S rRNA gene sequencing for identification of nonfermenting gram-negative bacilli recovered from patients attending a single cystic fibrosis center. J Clin Microbiol 2002 40 : 3793 7.
21. Clermont D, Harmant C, Bizet C. Identification of strains of Alcaligenes and Agrobacterium by a poliphasic approach. J Clin Microbiol 2001 39 : 3104 9.
22. Krzewinski JW, Nguyen CD, Foster JM, Burns JL. Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis. J Clin Microbiol 2001 39 : 3597 602.